| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0958-1669(98)80009-8 |
| P698 | PubMed publication ID | 9720263 |
| P50 | author | L. Mario Amzel | Q28031687 |
| P2093 | author name string | L Mario Amzel | |
| P2860 | cites work | Comparative protein modelling by satisfaction of spatial restraints | Q27860866 |
| Preparation of selenomethionyl proteins for phase determination | Q27860869 | ||
| The Protein Data Bank: a computer-based archival file for macromolecular structures | Q27860989 | ||
| Accurate modeling of protein conformation by automatic segment matching | Q28290861 | ||
| [28] Phase determination from multiwavelength anomalous diffraction measurements | Q30047434 | ||
| Calculating three-dimensional changes in protein structure due to amino-acid substitutions: the variable region of immunoglobulins | Q30404964 | ||
| A computational procedure for determining energetically favorable binding sites on biologically important macromolecules | Q30406755 | ||
| Structure-based drug design: progress, results and challenges | Q30419784 | ||
| Structure-based understanding of ligand affinity using human thrombin as a model system | Q30424298 | ||
| The computer program LUDI: a new method for the de novo design of enzyme inhibitors | Q33214112 | ||
| A geometric approach to macromolecule-ligand interactions | Q34280176 | ||
| ALADDIN: an integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures | Q34465525 | ||
| Automated docking of substrates to proteins by simulated annealing | Q34640538 | ||
| Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions | Q36749967 | ||
| GroupBuild: a fragment-based method for de novo drug design | Q36784871 | ||
| Design of enzyme inhibitors using iterative protein crystallographic analysis | Q37776468 | ||
| FOUNDATION: a program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three-dimensional databases | Q38565532 | ||
| A new method for building protein conformations from sequence alignments with homologues of known structure | Q39101556 | ||
| Ligand-protein docking and rational drug design. | Q40467213 | ||
| NMR at very high fields | Q40704393 | ||
| Docking small-molecule ligands into active sites | Q40926545 | ||
| Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery | Q41398194 | ||
| 'Flu' and structure-based drug design | Q41613210 | ||
| Combinatorial chemistry searching for a winning combination | Q43881364 | ||
| Empirical free energy as a target function in docking and design: application to HIV-1 protease inhibitors. | Q52306807 | ||
| Estimation of changes in side chain configurational entropy in binding and folding: general methods and application to helix formation. | Q52372237 | ||
| Entropy in biological binding processes: estimation of translational entropy loss. | Q52384808 | ||
| CLIX: A search algorithm for finding novel ligands capable of binding proteins of known three‐dimensional structure | Q52434109 | ||
| Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation. | Q54650033 | ||
| Automated docking with grid-based energy evaluation | Q56005218 | ||
| Strategy and Tactics in Combinatorial Organic Synthesis. Applications to Drug Discovery | Q56068732 | ||
| Critical assessment of methods of protein structure prediction (CASP): Round II | Q56171911 | ||
| Three-dimensional structure of an angiotensin II-Fab complex at 3 A: hormone recognition by an anti-idiotypic antibody | Q57000528 | ||
| Structural energetics of peptide recognition: Angiotensin II/antibody binding | Q57206223 | ||
| Modeling the variable region of immunoglobulins | Q57206228 | ||
| Overproduction of membrane proteins | Q57668033 | ||
| Antibody-directed drug discovery | Q59007175 | ||
| Knowledge based modelling of homologous proteins, Part I: Three-dimensional frameworks derived from the simultaneous superposition of multiple structures | Q68853089 | ||
| Docking enzyme-inhibitor complexes using a preference-based free-energy surface | Q71671442 | ||
| Structure-based thermodynamic analysis of HIV-1 protease inhibitors | Q73417508 | ||
| Loss of translational entropy in binding, folding, and catalysis | Q73427985 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 366-369 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Current Opinion in Biotechnology | Q15763085 |
| P1476 | title | Structure-based drug design | |
| P478 | volume | 9 |
| Q30725877 | A method for computational combinatorial peptide design of inhibitors of Ras protein |
| Q46229436 | A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis |
| Q30767591 | A rapid method to identify exo-protease inhibitors |
| Q34104950 | Apurinic/apyrimidinic endonuclease/redox effector factor-1(APE/Ref-1): a unique target for the prevention and treatment of human melanoma |
| Q38025633 | Basic research in HIV vaccinology is hampered by reductionist thinking |
| Q30978202 | Design, docking, and evaluation of multiple libraries against multiple targets |
| Q37490567 | Expression of a unique drug-resistant Hsp90 ortholog by the nematode Caenorhabditis elegans |
| Q92443122 | Identifying Ortholog Selective Fragment Molecules for Bacterial Glutaredoxins by NMR and Affinity Enhancement by Modification with an Acrylamide Warhead |
| Q33452082 | Insight into ligand selectivity in HCV NS5B polymerase: molecular dynamics simulations, free energy decomposition and docking |
| Q33743748 | Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationships in immunology |
| Q34189143 | Pitfalls of reductionism in the design of peptide-based vaccines |
| Q27317992 | REdiii: a pipeline for automated structure solution |
| Q27620782 | Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution |
| Q28071559 | Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory |
| Q33238328 | Structure-based development of target-specific compound libraries |
| Q33834114 | Structure-based inhibitor design |
| Q31401240 | The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors |
| Q59245627 | Discovery of Novel Druggable Sites on Zika Virus NS3 Helicase Using X-ray Crystallography-Based Fragment Screening |
| Q55016340 | Quantum Chemical Approaches in Structure-Based Virtual Screening and Lead Optimization. |
| Q38720600 | Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors |
| Q56962039 | Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces |
Search more.